Altogether, our study represents significant implications for clinical research and strongly supports the effectiveness of BCP as a novel molecule to target in the development of effective therapeutic agents for MS.
Link: (−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis
Year: 2017
DOI: 10.3390/ijms18040691
Possible to probable range of efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.
(−)-β-caryophyllene (BCP)